These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18362186)

  • 1. Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis.
    Alffenaar JW; de Vries PM; Luijckx GJ; van Soolingen D; van der Werf TS; van Altena R
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2293-5. PubMed ID: 18362186
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis.
    Alffenaar JW; van Altena R; Bökkerink HJ; Luijckx GJ; van Soolingen D; Aarnoutse RE; van der Werf TS
    Clin Infect Dis; 2009 Oct; 49(7):1080-2. PubMed ID: 19712035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
    Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
    Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography- tandem mass spectrometry method.
    Pranger AD; Alffenaar JW; Wessels AM; Greijdanus B; Uges DR
    J Anal Toxicol; 2010 Apr; 34(3):135-41. PubMed ID: 20406537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.
    Watt KM; Massaro MM; Smith B; Cohen-Wolkowiez M; Benjamin DK; Laughon MM
    Pediatr Infect Dis J; 2012 Feb; 31(2):197-9. PubMed ID: 22016080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of subconjunctival injection of moxifloxacin in humans.
    Matsuura K
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):1019-20. PubMed ID: 22552573
    [No Abstract]   [Full Text] [Related]  

  • 7. Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis.
    Peloquin CA; Hadad DJ; Molino LP; Palaci M; Boom WH; Dietze R; Johnson JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):852-7. PubMed ID: 18070980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing.
    Gardner SY; Davis JL; Jones SL; LaFevers DH; Hoskins MS; McArver EM; Papich MG
    J Vet Pharmacol Ther; 2004 Feb; 27(1):57-60. PubMed ID: 14995968
    [No Abstract]   [Full Text] [Related]  

  • 9. Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge system.
    Ginsburg AS; Lee J; Woolwine SC; Grosset JH; Hamzeh FM; Bishai WR
    Antimicrob Agents Chemother; 2005 Feb; 49(2):853-6. PubMed ID: 15673788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin and moxifloxacin for tuberculous meningitis.
    Ukwaja KN; Onyedum CC
    Lancet Infect Dis; 2013 Jul; 13(7):569-70. PubMed ID: 23809223
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampicin and moxifloxacin for tuberculous meningitis.
    Akkerman O; Pranger A; van Altena R; van der Werf T; Alffenaar JW
    Lancet Infect Dis; 2013 Jul; 13(7):568-9. PubMed ID: 23809221
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.
    Cárceles CM; Villamayor L; Escudero E; Marín P; Fernández-Varón E
    Vet J; 2007 Mar; 173(2):452-5. PubMed ID: 16377219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin and moxifloxacin for tuberculous meningitis--authors' reply.
    Ruslami R; Ganiem AR; Aarnoutse RE; van Crevel R;
    Lancet Infect Dis; 2013 Jul; 13(7):570. PubMed ID: 23809224
    [No Abstract]   [Full Text] [Related]  

  • 14. Moxifloxacin penetration in bronchial secretions of mechanically ventilated patients with pneumonia.
    Leone M; Albanèse J; Sampol-Manos E; Simon N; Lacarelle B; Bruguerolle B; Martin C
    Antimicrob Agents Chemother; 2004 Feb; 48(2):638-40. PubMed ID: 14742226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensified intravenous rifampicin in tuberculous meningitis.
    Brouwer MC; van de Beek D
    Lancet Infect Dis; 2013 Jan; 13(1):2-3. PubMed ID: 23103176
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep.
    Cárceles CM; Escudero E; Fernández-Varón E; Marín P
    Vet J; 2009 Jun; 180(3):343-7. PubMed ID: 18406644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves.
    Pathania R; Sharma SK
    Res Vet Sci; 2010 Aug; 89(1):108-12. PubMed ID: 20202656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis.
    Djukic M; Böttcher T; Wellmer A; Gerber J; Brocke VV; Eiffert H; Nau R
    Neurocrit Care; 2005; 2(3):325-9. PubMed ID: 16159084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    Stass H; Rink AD; Delesen H; Kubitza D; Vestweber KH
    J Antimicrob Chemother; 2006 Sep; 58(3):693-6. PubMed ID: 16895940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.
    Rink AD; Stass H; Delesen H; Kubitza D; Vestweber KH
    Clin Drug Investig; 2008; 28(2):71-9. PubMed ID: 18211115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.